Tumor lysis syndrome provides evidence for dose-intense response for corticosteroids in prolymphocytic leukemia.
Jones
R
R
Pipas
J M
JM
Kritz
A D
AD
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D011241:Prednisone